1157 EARLY HCVRNA DYNAMICS AND FACTORS ASSOCIATED WITH HIGH EARLY HCVRNA LEVEL DURING ACUTE HCV INFECTION
Behzad Hajarizadeh(UNSW Sydney), Gregory J. Dore(UNSW Sydney), Margaret Hellard(The Alfred Hospital), Barbara McGovern(Tufts Medical Center), Rachel Sacks‐Davis(Burnet Institute), Jakia Amin, Bart Grady(GGD Amsterdam), Jason Grebely(UNSW Sydney), Adam Lloyd, A.Y. Kim, Janke Schinkel(Amsterdam UMC Location University of Amsterdam), Lisa Maher(UNSW Sydney), Karen Page(Pfizer (United States)), Thomas Rice(University of Exeter), J. Bruneau, Martin Morris, Amanda Cox(Sorbonne Université), M.H. Prins
Cited by 2
Related Papers
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
|Nature Metabolism|2020|775
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
|The Lancet|2016|648
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539